Lakefront Biotherapeutics NV LKFT
34.07 USD -0.32 (-0.93%)
Regular-session close
34.52 +0.45 +1.32%
Pre-market · Nov 19, 4:06 AM ET
34.07 Day range 34.77
25.68 52-week range 36.24
- YTD
- +4.19%
- 1 year
- +12.00%
Benzinga news
benzinga.com Lakefront Biotherapeutics Board Creates 150,000 Subscription Rights Under New Subscription Right Plan Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) announced that its Board of Directors has created 150,000 subscription rights under a new subscription right plan on November 10, 2026.On…
benzinga.com Morgan Stanley Maintains Equal-Weight on Lakefront Biotherapeutics, Raises Price Target to $27 Morgan Stanley analyst Judah Frommer maintains Lakefront Biotherapeutics (NASDAQ:LKFT) with a Equal-Weight and raises the price target from $26 to $27.
benzinga.com Lakefront Biotherapeutics Q3 EPS €(0.04) Beats €(0.19) Estimate, Sales €7.569M Miss €8.680M Estimate Lakefront Biotherapeutics (NASDAQ:LKFT) reported quarterly losses of €(0.04) per share which beat the analyst consensus estimate of €(0.19) by 78.95 percent. This is a 98.7 percent increase over…
benzinga.com Vylor, Franco-Nevada On Deck Wednesday As New Coverage, Gold Prices Face Test Vylor headlines Wednesday’s reports as investors assess how the newly covered consumer-staples company will be received, while Franco-Nevada offers a read on precious-metals exposure after a strong…
